Walesky, Chad M. http://orcid.org/0000-0003-3800-3453
Kolb, Kellie E. http://orcid.org/0000-0001-8840-7363
Winston, Carolyn L. http://orcid.org/0000-0003-0140-2426
Henderson, Jake http://orcid.org/0000-0003-1981-359X
Kruft, Benjamin http://orcid.org/0000-0001-5964-0836
Fleming, Ira http://orcid.org/0000-0002-4691-6933
Ko, Sungjin http://orcid.org/0000-0002-6079-5939
Monga, Satdarshan P. http://orcid.org/0000-0002-8437-3378
Mueller, Florian http://orcid.org/0000-0002-9622-4396
Apte, Udayan http://orcid.org/0000-0002-6741-7164
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Goessling, Wolfram http://orcid.org/0000-0001-9972-1569
Article History
Received: 3 October 2019
Accepted: 12 October 2020
First Online: 19 November 2020
Competing interests
: W.G. is a consultant for Camp4 Therapeutics. A.K.S. reports compensation for consulting and/or SAB membership from Merck, Honeycomb Biotechnologies, Cellarity, Cogen Therapeutics, Ochre Bio, and Dahlia Biosciences. S.P.M has an advisory board role for Surrozen. C.M.W., K.E.K., C.L.W., J.H., B.K., I.F., F.M., S.K., and U.A. have no competing interests to declare.